GoodRx launch­es dis­count for Boehringer In­gel­heim's Hu­mi­ra biosim­i­lar

Boehringer In­gel­heim has part­nered with GoodRx to of­fer the drug­mak­er’s Hu­mi­ra biosim­i­lar, adal­i­mum­ab-adbm, in an­oth­er move by man­u­fac­tur­ers to try and wedge them­selves in­to a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER